logo for PCRX

PCRX • NASDAQ

Pacira BioSciences, Inc.

$36.39

+ Add to Watchlist

Stock Details

Market Cap 1,431,400,650
Day Change 11.19 (44.40%)
Volume 28,880,136
Avg Volume 549,171
Price Range 18.8-36.4

Overview

Country US
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ

Company Profile

Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a non-opioid, handheld cryoanalgesia device capable of delivering precisely controlled cold temperatures to targeted nerves. Pacira also develops its unique multivesicular liposome (MVL) drug delivery technology, which encapsulates therapeutic compounds while preserving their inherent molecular structure. Established in 2006, the firm was formerly known as Pacira Pharmaceuticals, Inc. until its name change to Pacira BioSciences, Inc. in April 2019. Its main corporate office is situated in Tampa, Florida.

Financial Overview

52 Week High 27.66
52 Week High Date 2026-08-04
52 Week Low 18.8
52 Week Low Date 2026-01-20
10D Avg Trading Vol 0.5409
YTD Price Return Daily -4.3277
MTD Price Return Daily -1.1577

Cash Flow

TTM/Share 1.93135
Annual/Share 3.3237
Quarterly/Share 4.5079

Price-to-Earnings

Annual Ratio 4.5441
Quarterly Ratio 5.0423
TTM 68.5016

Revenue

3Y Growth 2.9
5Y Growth 11.08
Annual/Share 6.24
TTM/Share 18.5152
5Y Share Growth 10.41

Earnings Per Share

Annual 0.1562
3Y Growth -22.98
5Y Growth -45.77
Quarterly YOY Growth

Price-to-Book

Ratio 1.4922
Annual Ratio 1.6064
TTM 1.4856